Who Will Be the Leaders of IVD Industry in China ?
First Announcement In Vitro Diagnostics China Summit 2007(IVD China 2007)
China Opportunities & Challenges of IVD Industryn Vitro Diagnostics in China
09.00-18.30, October 23-24, 2007
Holiday Inn, Century City Chengdu
No1, Middle Section, Tianfu Avenue, Chengdu, China
Organizers:
China Association for Medical Devices Industry (CAMDI)
Center for Clinical Laboratory Development,
Chinese Academy of Medical Sciences and Peking Union Medical College (CCLD)
Reed Sinopharm Exhibitions Co., Ltd. (RSE)
Co-Organizers:
Chinese Society of Laboratory Medicine (CSLM)
Chinese Medical Doctor Association of Lab Medicine (CMDAL)
Preliminary list of Media Partners:
China Pharmaceutical News
Medicine Economic News
Health News;
Chinese Journal of Medical Instrumentation
China Medical Device Information
International Medical Devices
China Hospital CEO
Health.sohu.com
www.tech-ex.com
www.cyy123.com
www.healthoo.com
Research Partner:
Frost & Sullivan
Value and Benefits for Conference Delegates
- Communicate with government officials, association leaders and industry experts
- Focus on the latest information of IVD market
- Detailed review and analysis of the latest regulations for IVD products in China
- Discuss with leading diagnostics manufacturers and distributors
- Network with leading investment bankers and venture capitalists
Promising IVD Market in China
There has not been a year in the last decade in which the IVD market in China has failed to grow. Combined with this impressive overall growth, a number of recent trends in the Chinese healthcare environment are making China an increasingly attractive and important market opportunity for in vitro diagnostics companies. Although there are a number of challenges for diagnostic manufacturers to understand and overcome, the market for clinical diagnostics in China (both reagents and instruments) remains one of the most promising emerging markets in the world. Meanwhile, the double-digit growth rate and opportunities for foreign firms will expand as China’s regulation of medical devices moves more in line with international practices.
The State Food and Drug Administration of PRC (SFDA) promulgated the “Registration Management Act for In Vitro Diagnostics Reagent (Trial)” and put in force from June 1, 2007. It is widely expected that the future Chinese IVD market will become more regulated with clearer standards, enable further broadening and development of the industry segment. In this regard, the In Vitro Diagnostics China Summit 2007 will be a timely and important platform for all the senior professionals to learn more about the recent developments and find out more market potentials of the Chinese IVD sector.
Who Should Attend
- CEO from China and overseas IVD enterprises, manufacturers and distributors
- Researchers and academics from universities, research centers and clinical laboratories
- Government officials
- Investors from investment banks, private equities, various funds, and venture capital firms
- Life science technology companies
- Service providers including consultants, accountants, legal professionals
Summary and Highlights
This conference offers a unique blend of recent regulatory developments, management insights and important business trends on IVD market. Attend and learn about
- The Macro Strategic Outlook for the IVD Industry
- Overview of Global IVD Trends and Opportunities
- Current Trends and Prospects for IVD Industry in China
- Explanation of the Latest IVD Registration Policies Process in China
- Update on the International Registry and Administration
- Analysis of the China IVD Reagent Market
- Development of IVD Instrument R&D in China
- Impact of China Medical Reform on IVD
- Impact of Global IVD M&A on Chinese IVD Companies
- Prospect and Important Role of Venture Capitalist in the Chinese IVD Market
- Market Entry Strategies for Foreign IVD Businesses Entering into China
- Case Studies: How Chinese IVD Reagents Register in the US and EU Markets
- Successful Cooperation among R&D, Manufacturing and Sales Distribution
List of Invited
State Food and Drug Administration (SFDA), PRC
Ministry of Health of The People’s Republic of China
China Association for Medical Devices Industry
Peking Union Medical College
Chinese Society of Laboratory Medicine
Chinese Medical Doctor Association of Lab Medicine
Chinese Journal of Laboratory Medicine
Mindray
Biosino Bio-Technology and Science Inc.
Kehua Biopharmaceutical
Fosun Pharma
……
Advanced Medical Technology Association
American Association of Clinical Chemistry
U.S. Food and Drug Administration (FDA)
Roche Diagnostics
Bayer Diagnostics (Siemens)
Beckman Coulter Inc.
Abbott (GE)
……
Introduction of CMEF and AHWP
In conjunction with IVD China 2007, an international medical equipment fair and an international conference on medical device regulation will be held in Chengdu.
CMEF - Asia Pacific’s largest trade fair serving the entire value chain for the medical device market. With an unrivalled annual exhibition space of more than 160,000 square meters, the CMEF has become the No.1 procurement center for medical devices of the Asia Pacific region. Constantly moving in pace with the industry and technology, CMEF has been giving strategic focus on the IVD (In Vitro Diagnosis) sector. In this show in Chengdu, CMEF will feature even more IVD contents, including high-profile conferences and industry leading seminars. Be part of the CMEF academic clusters and gain access to the latest know-how in IVD market.
Visiting www.cmef.com.cn for more details.
The Asian Harmonization Working Party (AHWP) will convene its 12th Meeting on 23th-27th October 2007 in Chengdu, People's Republic of China. This meeting provides another forum for discussion on pertinent issues and commitment towards the convergence of medical devices regulatory requirements in the Asia Pacific region. It will discuss the progress of the ongoing activities under the AHWP's work program as well as the way forward for AHWP.
Visiting www.asiahwp.org for more details.
For more informaiton, please Download the Application Form